CLINICAL-PATOGENETIC RATIONALE FOR THE USE OF GLYCOSAMINOGLYCANS IN THE TREATMENT OF PATIENTS WITH GLOMERULONEPHRITIS. Art of Medicine, [S. l.], v. 28, n. 4, p. 88–93, 2023. DOI: 10.21802/artm.2023.4.28.88. Disponível em: https://art-of-medicine.ifnmu.edu.ua/index.php/aom/article/view/1060.. Acesso em: 24 jun. 2026.